From Freedom Ride to Gender-based Biology

Barbara Mikulski If there is more "bullwhip and buzz saw" than "serenade by starlight" in the persona of U.S. Sen. Barbara A. Mikulski (D-Md.), it's because she isn't afraid to batter feelings in fighting for what she believes in. Certainly, not everyone likes the outspoken way she cuts through business-as-usual in pursuit of her goals. "Barbara, you just don't have a therapeutic personality," is how one of her teachers once put it, and Mikulski proudly declares that Ronald Reagan, George Bush,

Written byTom Hollon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


Barbara Mikulski
If there is more "bullwhip and buzz saw" than "serenade by starlight" in the persona of U.S. Sen. Barbara A. Mikulski (D-Md.), it's because she isn't afraid to batter feelings in fighting for what she believes in. Certainly, not everyone likes the outspoken way she cuts through business-as-usual in pursuit of her goals. "Barbara, you just don't have a therapeutic personality," is how one of her teachers once put it, and Mikulski proudly declares that Ronald Reagan, George Bush, and Bill Clinton all agree. "And that's what they thought at [the National Institutes of Health] 10 years ago," she adds, recalling the day of what she calls her Freedom Ride, when she drove with three like-minded female colleagues from the capitol to NIH's Bethesda campus and embarrassed NIH into making a sea change in its women's health research--namely, to have some.

In 1990, Mikulski was outraged to learn ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies